Zivo Bioscience
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $31 | $0 | $35 | $11 |
Gross Profit | 9 | 0 | 12 | 4 |
EBITDA | -2,260 | -8,229 | -1,275 | -1,896 |
EBIT | -2,260 | -1,319 | -2,606 | |
Net Income | -2,268 | -8,236 | -1,278 | -1,908 |
Net Change In Cash | 31 | 0 | 35 | 11 |
Free Cash Flow | -1,085 | -623 | -1,699 | -715 |
Cash | 159 | 2 | 138 | 274 |
Basic Shares | 3,410 | 2,961 | 2,748 | 1,735 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $27 | $4 | $0 | $20 |
Gross Profit | 11 | 0 | 20 | |
EBITDA | -7,263 | -8,731 | -9,608 | -8,555 |
EBIT | -7,702 | -8,731 | -9,052 | -8,555 |
Net Income | -7,777 | -8,745 | -9,396 | -9,655 |
Net Change In Cash | 27 | 4 | 0 | 20 |
Cost of Revenue | -208 | |||
Free Cash Flow | -5,799 | -7,102 | -6,803 | -2,588 |
Cash | 274 | 1,799 | 8,901 | 137 |
Basic Shares | 1,690 | 1,569 | 1,271 | 846 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.67 |
2024-06-30 | -$2.78 |
2024-03-31 | -$0.47 |
2023-12-31 | -$0.96 |
